Corpus Intelligence IC Memo — ASSURANCE HEALTH INDIANAPOLIS 2026-04-26 15:03 UTC
IC Memo — ASSURANCE HEALTH INDIANAPOLIS
Investment Committee Memorandum | IN | 43 beds | Grade D | EBITDA uplift $993K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ASSURANCE HEALTH INDIANAPOLIS

CCN 154064 | MARION, IN | 43 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

ASSURANCE HEALTH INDIANAPOLIS is a 43-bed rural/critical access in MARION, IN with $13.5M in net patient revenue and a 12.9% operating margin. The hospital serves a payer mix of 75.4% Medicare, 2.9% Medicaid, and 21.7% commercial.

Thesis: Turnaround. Our ML models identify $993K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 12.9% to 20.2% (+737bps).

Net Revenue HCRIS$13.5M
Current EBITDA COMPUTED$1.7M
Operating Margin COMPUTED12.9%
Occupancy HCRIS83.4%
Revenue / Bed COMPUTED$313K
Net-to-Gross HCRIS60.3%
Distress Probability ML46.6%

2. Market Context & Competitive Position

171
IN Hospitals
-1.1%
State Median Margin
89
Comparable Hospitals

IN has 171 Medicare-certified hospitals with a median operating margin of -1.1%. The target's margin of 12.9% places it above the state median. Among 89 size-comparable peers (22-86 beds), the median margin is -1.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (22-86), prioritizing same-state peers. 89 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ASSURANCE HEALTH INDIANAPOLIS (Target)IN43$13.5M12.9%
INDIANA ORTHOPAEDIC HOSPITAL LIN38$196.8M31.2%
LAPORTE HOSPITALIN74$192.4M19.3%
SCHNECK MEDICAL CENTERIN60$184.2M-0.8%
ORTHOPAEDIC HOSPT.AT PARKVIEWIN37$175.7M36.8%
LUTHERAN MUSCULOSKELETAL CENTEIN39$168.9M25.0%
WITHAM MEMORIAL HOSPITALIN50$158.5M-11.6%
FRANCISCAN HEALTH MOORESVILLEIN80$157.3M26.2%
MAJOR HOSPITALIN46$156.9M-9.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $993K (737bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$283K+210bp18mo
Cost to Collect4.5%2.5%$269K+200bp12mo
Denial Rate Reduction12.0%6.5%$267K+199bp12mo
A/R Days Reduction5200.0%3800.0%$164K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+7bp6mo

5. EBITDA Bridge

Net Collection Rate
$283K
Cost to Collect
$269K
Denial Rate Reduction
$267K
A/R Days Reduction
$164K
Clean Claim Rate
$10K
Total EBITDA Uplift$993K
Current EBITDA$1.7M
+ RCM Uplift+$993K
Pro Forma EBITDA$2.7M
Current Margin12.9%
Pro Forma Margin20.2%
WC Released (1x)$516K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$2.7M$21.3M8.02x51.6%
Base (11x exit)10.0x11.0x$2.7M$24.3M9.14x55.7%
Bull Case9.0x11.0x$2.4M$28.5M11.88x64.1%
Bull (12x exit)9.0x12.0x$2.4M$31.8M13.26x67.7%
Bear Case11.0x10.0x$2.9M$15.5M5.30x39.6%
Bear (11x exit)11.0x11.0x$2.9M$18.0M6.15x43.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 75.4% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 89 hospitals with 22-86 beds
  • Same-state prioritization (n=90)
  • Comp margins: P25=-11.9% / P50=-1.8% / P75=8.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.